NASDAQ:SNES - SenesTech Stock Price, Forecast & News

SenesTech trades on the NASDAQ under the ticker symbol "SNES."

SenesTech Inc (NASDAQ:SNES) issued its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.09) earnings per share (EPS) for the quarter. The company earned $0.04 million during the quarter, compared to analyst estimates of $0.04 million. SenesTech had a negative net margin of 4,568.52% and a negative return on equity of 200.80%. View SenesTech's Earnings History.

SenesTech is scheduled to release their next quarterly earnings announcement on Thursday, March 26th 2020. View Earnings Estimates for SenesTech.

Media stories about SNES stock have trended very negative on Saturday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. SenesTech earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for SenesTech.

Some companies that are related to SenesTech include Evogene (EVGN), Arcadia Biosciences (RKDA), China Green Agriculture (CGA), Eden Research (EDEN), Bion Environmental Technologies (BNET), Kiwa Bio-Tech Products Group (KWBT) and Cavitation Technologies (CVAT).

Based on aggregate information from My MarketBeat watchlists, some companies that other SenesTech investors own include TransEnterix (TRXC), Carrizo Oil & Gas (CRZO), Marathon Oil (MRO), McDermott International (MDR), Auris Medical (EARS), Melinta Therapeutics (MLNT), ZIOPHARM Oncology (ZIOP), Adamis Pharmaceuticals (ADMP), Catabasis Pharmaceuticals (CATB) and Citius Pharmaceuticals (CTXR).

(SNES) raised $15 million in an initial public offering on Thursday, December 8th 2016. The company issued 1,900,000 shares at $8.00 per share. Roth Capital Partners served as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.

Shares of SNES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SNES stock can currently be purchased for approximately $0.36.

SenesTech has a market capitalization of $10.10 million and generates $300,000.00 in revenue each year. The company earns $-11,910,000.00 in net income (profit) each year or ($0.63) on an earnings per share basis. SenesTech employs 40 workers across the globe.View Additional Information About SenesTech.

The official website for SenesTech is http://www.senestech.com/.

SenesTech's mailing address is 3140 NORTH CADEN COURT SUITE 1, FLAGSTAFF AZ, 86004. The company can be reached via phone at 928-779-4143 or via email at [email protected]